| 1 |
Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects |
|
| | Nowshin Papri, Zhahirul Islam, Sonja E. Leonhard, Quazi D. Mohammad, Hubert P. Endtz, Bart C. Jacobs | | | Nature Reviews Neurology. 2021; 17(5): 285 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Use of angiotensin converting enzyme inhibitors in patients receiving therapeutic plasma exchange with a centrifuge-based apheresis system |
|
| | Soo Min Jang, Khaled Bahjri, Joanna Lee, Sanaz Nabavi, Amir Abdipour | | | Therapeutic Apheresis and Dialysis. 2021; 25(4): 497 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barré syndrome |
|
| | Hind A. Beydoun, May A. Beydoun, Sharmin Hossain, Alan B. Zonderman, Shaker M. Eid | | | Muscle & Nerve. 2020; 61(5): 608 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study |
|
| | Badrul Islam, Zhahirul Islam, Shafiqur Rahman, Hubert P Endtz, Margreet C Vos, Mathieu van der Jagt, Peter A van Doorn, Bart C Jacobs, Quazi Deen Mohammad | | | BMJ Open. 2018; 8(8): e022862 | | | [Pubmed] [Google Scholar] [DOI] | |
|
